Metabolic syndrome treatment: focusing on acarbose

Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients with impaired glucose tolerance (IGT) and AH.Mat...

Full description

Saved in:
Bibliographic Details
Main Authors: I. E. Chazova, B. B. Mychka
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-04-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1331
Tags: Add Tag
No Tags, Be the first to tag this record!